New data suggests the risk of blood clots from Astra-Zeneca is 1 in 60,000.
Ontario is going to pause first doses of the Oxford Astra-Zeneca vaccine over concerns around blood clots.
Chief Medical Officer of Health Dr. David Williams made the announcement during a press briefing this afternoon. New data suggests the risk of blood clots from Astra-Zeneca is higher then previously thought at 1 in 60,000.
This is not expected to impact the vaccine rollout in Ontario thanks to increased supply from Pfizer and Moderna.
The Province is currently reviewing data for second doses and it is possible those who got the first shot of Astra-Zeneca could end up with a second dose from Pfizer or Moderna. According to recent data, the risk of blood clots from the second dose of Astra-Zeneca is much smaller.
Dr. Williams did say anyone who already received the first dose of Astra-Zeneca did the right thing and this decision was made out of an abundance of caution. He notes the increased supply of Moderna and Pfizer helped make this an easier decision.

3rd Annual Running with the Bulls Shines
Mischief in Tillsonburg is Under Investigation
Upgrades Completed for Woodstock Disc Golf Course
OPP Enforcement for Civic Holiday Weekend
Woodstock Candidate Profile - Anthony Scalisi
Drug Trafficking Investigation Leads to Charges
EZT Candidate Profile - Don Chowan
Oxford County Requesting Public Input
Norwich Man Charged in Brant County
SPWH Wants You to Know Drinking Risks
Charges Laid after Truck Hits Bridge
Ingersoll Candidate Profile - Mike Tucker
Motorcyclist Killed in Oxford Collision
Tip Tuesday with the Oxford OPP - July 2026
Oxford OPP Briefs - July 28th, 2026
Cat Thrown from Vehicle in Norfolk County
Environment Canada Issues Yellow Watch for Thunderstorms
Oxford Mosquito Traps Tests Positive for West Nile
Woodstock Candidate Profile - Sandeep Sidhu
Comments
Add a comment